Clinical Trials on Attention Deficit Hyperactivity Disorder (ADHD) in United Kingdom

Total 975 results

Children's National Research Institute

Recruiting

Technology-Enhanced Executive Functioning Intervention for ADHD

ADHD | Attention Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder | Attention Deficit Disorder | ADD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - Impulsive | Attention-Deficit Disorder in Adolescence | Attention-Deficit Hyperactivity...

United States
King's College London

Unknown

The Relationship of Essential Fatty Acids to Adult ADHD: The OCEAN Study (Oils and Cognitive Effects in Adult ADHD Neurodevelopment) (OCEAN)

Attention Deficit Hyperactivity Disorder (ADHD)

United Kingdom
Takeda

Completed

A Study on the Use of Healthcare Resources and Costs of Attention Deficit Hyperactivity Disorder (ADHD) in Adults in England

Attention Deficit Hyperactivity Disorder (ADHD)

United Kingdom
King's College London
Shire

Completed

Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD) (BCADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

United Kingdom
Cingulate Therapeutics

Recruiting

Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301

ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit Hyperactivity

United States
Ironshore Pharmaceuticals and Development, Inc

Completed

A Study of Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) in Children With ADHD (HLD100-103)

Attention-Deficit Hyperactivity Disorder (ADHD)

United States
Spanish Foundation for Neurometrics Development
PronoKal Foundation; Child Health Foundation

Completed

Neurocognitive and Neurobiological Improvement in ADHD Children by Modification of Dietary Protein (BrainProtein)

ADHD | ADD

United Kingdom
Massachusetts General Hospital
Shire

Completed

Effect of Vyvanse on Driving in Young Adults With ADHD

Attention Deficit/Hyperactivity Disorder(ADHD)

United States
Cingulate Therapeutics
Premier Research Group plc

Active, not recruiting

Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301

ADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit Hyperactivity

United States
Medical University of South Carolina
Shire

Completed

Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD

Adult Attention Deficit Hyperactivity Disorder (ADHD)

United States
Massachusetts General Hospital
The American Professional Society of ADHD and Related Disorders (APSARD)

Completed

Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study

Attention Deficit Hyperactivity Disorder (ADHD) | Executive Function Deficits (EFD)

United States
King's College London
South London and Maudsley NHS Foundation Trust

Completed

Experimental Medicine in ADHD - Cannabinoids (EMA-C)

Attention Deficit Hyperactivity Disorder (ADHD)

United Kingdom
Novartis

Completed

Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

ADHD, ADD

United States
NHS Tayside
Zentralinstitut für Seelische Gesundheit Mannheim; Universita degli Studi di... and other collaborators

Completed

Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE)

Attention Deficit Hyperactivity Disorder (ADHD)

United Kingdom, Germany, Hungary, Italy
Cingulate Therapeutics
Rho, Inc.

Completed

Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.

ADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined

United States
Tris Pharma, Inc.
Massachusetts General Hospital; Massachusetts Institute of Technology

Completed

Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)

ADHD

United States
Massachusetts General Hospital

Completed

Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits

Attention Deficit Hyperactivity Disorder (ADHD) | Deficient Emotional Self-Regulation (DESR)

United States
AstraZeneca
Targacept Inc.

Completed

An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)

ADHD

United States
King's College London
South London and Maudsley NHS Foundation Trust

Completed

Female Experiences and Brain Activity (FEBA)

Bipolar Disorder | ADHD | Attention Deficit Hyperactivity Disorder

United Kingdom
University of Nottingham
National Institute for Health Research, United Kingdom

Completed

Assessing QbTest Utility in ADHD: A Randomised Controlled Trial (AQUA2)

Attention Deficit Hyperactivity Disorder (ADHD)

United Kingdom
Shire

Withdrawn

Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

ADHD

United States
Seattle Children's Hospital

Completed

Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)

Attention Deficit/Hyperactivity Disorder (ADHD)

United States
Targacept Inc.

Completed

Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD)

ADHD

United States
Massachusetts General Hospital
Neurocentria, Inc.

Completed

L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD

ADHD | Attention Deficit/Hyperactivity Disorder

United States
Yale University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD) (IBBS)

Attention Deficit Hyperactivity Disorder (ADHD)

China, United States
Think Now Incorporated
National Institute of Mental Health (NIMH); University of California, Los Angeles

Completed

Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD) (NAT-I)

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Aevi Genomic Medicine, LLC, a Cerecor company
Children's Hospital of Philadelphia; Thomas Jefferson University; Pearson/Clinical...

Completed

Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder (NFC1-GREAT)

Attention-deficit Hyperactivity Disorder (ADHD)

United States
Massachusetts General Hospital
Shire

Completed

Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults

Attention Deficit Hyperactivity Disorder (ADHD)

United States
BioLite, Inc.

Completed

A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)

Attention-Deficit Hyperactivity Disorder (ADHD)

United States
Enzymotec

Completed

Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

United States
BioLite, Inc.
ABVC BioPharma, Inc

Suspended

PDC-1421 Treatment in Adult Patients With ADHD

Attention-Deficit Hyperactivity Disorder (ADHD)

United States, Taiwan
Shire

Completed

Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Neos Therapeutics, Inc

Completed

NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Sunovion

Completed

A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.

Attention-Deficit Hyperactivity Disorder (ADHD)

United States
Shire

Completed

Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Neurocentria, Inc.

Recruiting

Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD (ADHD)

Attention-Deficit/Hyperactivity Disorder (ADHD)

United States
University of Pennsylvania

Completed

Transcranial Magnetic Stimulation for Attention Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity (ADHD)

United States
Sunovion

Completed

A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.

Attention-Deficit Hyperactivity Disorder (ADHD)

United States
Shire

Completed

Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

Germany, Italy, Poland, Spain, Romania, Belgium, Hungary, Netherlands, Sweden, United Kingdom
Alcobra Ltd.

Completed

A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity )

ADHD | Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type

United States, Israel
Alcobra Ltd.

Terminated

The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD

Attention Deficit Hyperactivity Disorder (ADHD)

United States, Israel
Cephalon

Completed

Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD

ADHD | Attention Deficit/Hyperactivity Disorder

United States
Icahn School of Medicine at Mount Sinai
National Institute on Drug Abuse (NIDA)

Recruiting

Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk (MPH-ATX)

ADHD | Attention Deficit Hyperactivity Disorder

United States
NYU Langone Health
National Institute of Mental Health (NIMH)

Completed

Brain Plasticity Underlying Acquisition of New Organizational Skills in Children

ADHD | Neurodevelopmental Disorders | Attention Deficit Hyperactivity Disorder

United States
Supernus Pharmaceuticals, Inc.

Completed

Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 4)

Attention Deficit Hyperactivity Disorder (ADHD)

United States
NYU Langone Health

Completed

Organizational Skill Training (OST) in Schools

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Florida International University

Completed

Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?

ADHD

United States
Florida International University

Completed

Open Trial of a Program to Support Parents of Children With Attention-deficit/Hyperactivity Disorder (ADHD)

ADHD

United States
University of California, Los Angeles
National Institute of Mental Health (NIMH)

Completed

Trigeminal Nerve Stimulation for ADHD (TNS for ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

United States
James McGough
National Institute of Mental Health (NIMH)

Completed

12 Month Open Extension of TNS for ADHD.

Attention Deficit Hyperactivity Disorder (ADHD)

United States

Clinical Trials on Attention Deficit Hyperactivity Disorder (ADHD) in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations